Skip to main content

AGC Pharma Chemicals is pleased to announce its participation in Swiss Biotech Day 2025, one of Europe’s leading conferences for the biotechnology and life sciences sectors. The event will take place on May 5–6 at the Congress Center Basel, Switzerland. 

Swiss Biotech Day is known for bringing together innovators, decision-makers, and industry leaders from across Europe and beyond. With its focus on networking, R&D, and cross-border collaboration, it provides an ideal platform for AGC Pharma Chemicals to showcase its integrated capabilities in small molecule API development and manufacturing. 

During the two-day event, our team will be available to meet with attendees and discuss how we support biotech companies throughout the product lifecycle—from clinical supply to commercial manufacturing. We will also highlight our expertise in high-containment manufacturing, regulatory compliance, and flexible scale-up solutions tailored to complex development needs. 

AGC Pharma Chemicals is proud to contribute to this unique event and to explore new opportunities for partnership and innovation in the heart of Europe’s biotech ecosystem. 

Latest News

Events & ConventionsAGC Pharma Chemicals to Attend the 54th Organic Process Research & Development Conference in Lisbon
26th September 2025

AGC Pharma Chemicals to Attend the 54th Organic Process Research & Development Conference in Lisbon

AGC Pharma Chemicals will be attending the 54th Organic Process Research and Development Conference in Lisbon from September 29 to October 1, 2025. This premier gathering of process chemists and…
NoticiasAGC Pharma Chemicals inaugurates a new advanced manufacturing plant in Malgrat de Mar (Barcelona), with an investment of over 100 million euros
25th September 2025

AGC Pharma Chemicals inaugurates a new advanced manufacturing plant in Malgrat de Mar (Barcelona), with an investment of over 100 million euros

AGC Pharma Chemicals inaugurated its new state-of-the-art manufacturing plant in Malgrat de Mar, Barcelona, representing an investment of over 100 million euros. The new facility marks a key milestone in…
All of ArticlesCDMO ProcessesThe Power of Small Particles: Understanding Micronization in Small Molecule APIs
26th June 2025

The Power of Small Particles: Understanding Micronization in Small Molecule APIs

Did you know that over 70% of new drug molecules face significant bioavailability challenges? The Paradigm Shift in Pharma With over 30% of active pharmaceutical ingredients (APIs) requiring micronization and…